Literature DB >> 3415353

A medical follow-up of the health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

R G Evans1, K B Webb, A P Knutsen, S T Roodman, D W Roberts, J R Bagby, W A Garrett, J S Andrews.   

Abstract

The human health effects of long-term exposure to low levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) have not been well established. The results of a prior study showed that persons exposed to TCDD had depressed cell-mediated immunity, and 18 of 51 persons had anergy or relative anergy on skin testing. This paper presents the results of a medical follow-up on participants who were reported to be anergic or relatively anergic in the earlier study. None of the participants in the follow-up study was anergic, and only one exposed and one unexposed participant were relatively anergic. Several technical and biological possibilities for the difference in results of the two studies are presented. The possibility that recovery from the effects of TCDD exposure caused the differing results is the least plausible explanation for the changes in the skin test results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415353     DOI: 10.1080/00039896.1988.10545949

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  8 in total

1.  Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  R Neubert; U Jacob-Müller; R Stahlmann; H Helge; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Penetration, distribution and kinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human skin in vitro.

Authors:  L W Weber; A Zesch; K Rozman
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.

Authors:  J D Holding; W E Lindup; D A Bowdler; M Z Siodlak; P M Stell
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

4.  Morbidity study of extruder personnel with potential exposure to brominated dioxins and furans. I. Results of blood monitoring and immunological tests.

Authors:  M A Zober; M G Ott; O Päpke; K Senft; C Germann
Journal:  Br J Ind Med       Date:  1992-08

5.  Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W Halperin; R Vogt; M H Sweeney; G Shopp; M Fingerhut; M Petersen
Journal:  Occup Environ Med       Date:  1998-11       Impact factor: 4.402

6.  Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.

Authors:  D Jung; P A Berg; L Edler; W Ehrenthal; D Fenner; D Flesch-Janys; C Huber; R Klein; C Koitka; G Lucier; A Manz; A Muttray; L Needham; O Päpke; M Pietsch; C Portier; D Patterson; W Prellwitz; D M Rose; A Thews; J Konietzko
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

Review 7.  Biomarkers for Great Lakes priority contaminants: halogenated aromatic hydrocarbons.

Authors:  M M Feeley
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

Review 8.  Immunological effects of chlorinated dibenzo-p-dioxins.

Authors:  N I Kerkvliet
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.